15-min delayed · Aug 27, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for BRTX yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $0.21 current
Highest Target—
Average Target—
Lowest Target—
BRTX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.13 – $-0.13 · 1 analysts · -61% YoY
Next period, 1 analysts expect BioRestorative Therapies Inc to earn $-0.13 a share (range $-0.13 – $-0.13), versus $-0.33 a year earlier. Full-year consensus is $-0.66, growing to $-0.52 the year after.
REVENUE · NEXT QUARTER
$370.0K
Range $90.0K – $650.0K · 1 analysts · +3036% YoY
Revenue is expected to reach $370.0K (range $90.0K – $650.0K), +3035.6% year-over-year. Full-year consensus is $1.4M, rising to $2.3M next year.
Top analysts covering BioRestorative Therapies Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BRTX.
#1
Jonathan Aschoff
Roth MKM · Rank #444
Buy
$15.00+7090.8% to target
Overall win rate
28%
+ Follow
#2
Michael Okunewitch
Maxim Group
Buy
$1.00+379.4% to target
Coverage
—
+ Follow
BRTX stock forecast FAQ
Who is the most accurate analyst covering BRTX?+
Among analysts who currently cover BRTX, Jonathan Aschoff of Roth MKM has the strongest overall Quantellect track record (Rank #444). Their current call is Buy with a $15.00 target.
What is BioRestorative Therapies Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.13 – $-0.13) across 1 analysts. Full-year EPS is projected at $-0.66, rising to $-0.52 the following year.
How much revenue is BioRestorative Therapies Inc expected to report next quarter?+
Consensus revenue is $370.0K (range $90.0K – $650.0K). Full-year revenue is projected at $1.4M, growing to $2.3M next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BRTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
